Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company value investors might notice is biote Corp. (BTMD). BTMD is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 12.10. This compares to its industry's average Forward P/E of 20.99. BTMD's Forward P/E has been as high as 19.29 and as low as -54.89, with a median of 13.22, all within the past year.
Finally, we should also recognize that BTMD has a P/CF ratio of 13.89. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. BTMD's P/CF compares to its industry's average P/CF of 37.96. Within the past 12 months, BTMD's P/CF has been as high as 61.62 and as low as -17.49, with a median of 17.82.
Investors could also keep in mind OraSure Technologies (OSUR), an Medical - Products stock with a Zacks Rank of # 2 (Buy) and Value grade of A.
OraSure Technologies also has a P/B ratio of 0.69 compared to its industry's price-to-book ratio of 7.58. Over the past year, its P/B ratio has been as high as 1.51, as low as 0.66, with a median of 0.81.
Value investors will likely look at more than just these metrics, but the above data helps show that biote Corp. and OraSure Technologies are likely undervalued currently. And when considering the strength of its earnings outlook, BTMD and OSUR sticks out as one of the market's strongest value stocks.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
biote Corp. (BTMD) : Free Stock Analysis Report
OraSure Technologies, Inc. (OSUR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。